Asari Ekpenyong

4PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 21, 2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.

Nabil F Saba, Ritu Chaudhary, Kedar Kirtane

|Feb 23, 2024
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer.

Fanghui Chen, Chris Tang, Fan Yang

|Apr 03, 2023
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.

Nabil F Saba, Conor E Steuer, Asari Ekpenyong

Pageof 1

Frequent Collaborators

4 joint publications

Nabil F Saba

3 joint publications

Ashley McCook-Veal

3 joint publications

Nicole C Schmitt

3 joint publications

William Stokes